Skip to content

Drug interactions

Glipizide + Ivacaftor

Severity: Minor

Glipizide and Ivacaftor: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivacaftor is a weak inhibitor of CYP2C9 in vitro, which could modestly raise exposure to CYP2C9 substrates such as glipizide. The clinical effect is expected to be small, but higher sulfonylurea levels could cause hypoglycemia.

What this interaction means in plain words

Glipizide and Ivacaftor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Glipizide belongs to Endocrine; Ivacaftor belongs to Miscellaneous.

Evidence level: Low

Why it happens

Weak inhibition of CYP2C9 by ivacaftor may reduce the metabolic clearance of glipizide.

What to do

Monitor blood glucose when ivacaftor is started or stopped in a patient on glipizide. Lower the sulfonylurea dose if hypoglycemia occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glipizide and Ivacaftor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glipizide with Ivacaftor?

MediHelp rates the interaction as minor. Glipizide and Ivacaftor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ivacaftor is a weak inhibitor of CYP2C9 in vitro, which could modestly raise exposure to CYP2C9 substrates such as glipizide. The clinical effect is expected to be small, but higher sulfonylurea levels could cause hypoglycemia.

How serious is the interaction between Glipizide and Ivacaftor?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when ivacaftor is started or stopped in a patient on glipizide. Lower the sulfonylurea dose if hypoglycemia occurs.

What other medicines interact with Ivacaftor?

MediHelp also lists interactions of Ivacaftor with, for example, Ensitrelvir, Apalutamide, Carbamazepine. The full list is on the Ivacaftor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in